CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding CervoMed Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 0 | 15 | +15 |
| Shares | 0 | 208.0K | +208.0K |
| Value | $0 | $1.39M | +$1.39M |
New holders (15)
Institutions that held CervoMed Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 79,970 | $534.0K | 0.00% |
| Renaissance Technologies LLC | 48,773 | $326.0K | 0.00% |
| BlackRock Inc. | 32,852 | $219.0K | 0.00% |
| Geode Capital Management, LLC | 17,165 | $112.0K | 0.00% |
| Bridgeway Capital Management, LLC | 16,565 | $109.0K | 0.00% |
| Trexquant Investment LP | 10,631 | $71.0K | 0.00% |
| Morgan Stanley | 548 | $4.00K | 0.00% |
| Advisor Group Holdings, Inc. | 600 | $4.00K | 0.00% |
| UBS Group AG | 430 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 245 | $2.00K | 0.00% |
| Wells Fargo & Company | 126 | $1.00K | 0.00% |
| Credit Suisse AG | 79 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 10 | $0 | 0.00% |
| Coastal Capital Group, Inc. | 9 | $0 | 0.00% |
| Strategic Asset Management, LLC | 40 | $0 | 0.00% |
Sold out (0)
Institutions that held CervoMed Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
None.